GO:0050803 regulation of synapse structure or activity: Biological Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050803 (regulation of synapse structure or activity) is a biological process that modulates the physical form or activity of a synapse, the junction between a neuron and a target cell.
• Synapse regulation depends on activity-dependent intracellular signaling, actin cytoskeleton dynamics, ubiquitin-proteasome degradation, and complement-mediated phagocytosis.
• Key molecular players include Cdc42, Ephexin5, CD55, actin regulators, and synaptic scaffolds such as those at electrical synapses.
• Dysregulation of synapse structure or activity is linked to schizophrenia, Parkinson's disease, and other neurological conditions.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of genes controlling synapse regulation.
• EDITGENE provides end-to-end CRISPR services including cell model generation, library screening, and bioinformatics for synapse research.
Description
The regulation of synapse structure or activity (GO:0050803) encompasses any process that modulates the physical form or the activity of a synapse, the junction between a neuron and a target cell such as another neuron, a muscle, or a secretory cell. This biological process is fundamental to neural circuit function, learning, and memory, and its disruption underlies numerous neurological and psychiatric disorders. Synapses are highly dynamic structures whose strength and morphology are continuously adjusted in response to activity, a property known as synaptic plasticity. Understanding how synapses are regulated requires integrating molecular mechanisms including cytoskeletal remodeling, protein degradation, and immune-mediated pruning. Research into GO:0050803 has revealed that activity-dependent signaling pathways control spine and synapse formation, while ubiquitin-dependent mechanisms govern synaptic protein turnover. Moreover, recent studies highlight the role of complement-mediated synaptic phagocytosis in disease contexts such as Parkinson's disease, where exercise training upregulates CD55 to suppress this process. The breadth of this GO term makes it a central node for neuroscientists studying development, degeneration, and therapeutic intervention.
regulation of synapse structure or activity At A Glance
| GO ID | GO:0050803 |
|---|---|
| GO term | regulation of synapse structure or activity |
| Ontology | biological_process |
| Synonym | None |
| Major function | Modulates the physical form or activity of a synapse, the junction between a neuron and a target cell |
| Related processes | Synaptic plasticity, cytoskeletal remodeling, ubiquitin-dependent degradation, complement-mediated phagocytosis |
| Key molecular players | Cdc42, Ephexin5, CD55, actin regulators, synaptic scaffolds |
| Disease relevance | Schizophrenia, Parkinson's disease, other neurological disorders |
What Is GO:0050803?
According to the Gene Ontology, GO:0050803 (regulation of synapse structure or activity) is defined as any process that modulates the physical form or the activity of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell). This definition captures both structural plasticity (changes in synapse size, number, or morphology) and functional plasticity (changes in synaptic strength or transmission efficiency). The term is a biological process and does not have synonyms in the QuickGO database.
Why Is regulation of synapse structure or activity Important in Cell Biology?
GO:0050803 is critically important because synaptic regulation is the cellular basis for information processing in the nervous system, and its dysfunction is a common feature of many brain disorders. Activity-dependent changes in synapse structure and strength underlie learning and memory, while aberrant regulation contributes to cognitive deficits in schizophrenia and neurodegeneration. Understanding the molecular mechanisms that control synapse regulation can reveal therapeutic targets and biomarkers for neurological and psychiatric diseases.
• Synaptic regulation is essential for neural circuit development and plasticity.
• Dysregulation of synapse structure or activity is implicated in schizophrenia.
• Complement-mediated synaptic phagocytosis contributes to Parkinson's disease pathology.
• Ubiquitin-dependent regulation controls synaptic protein turnover and synapse elimination.
• Actin dynamics are a core mechanism for structural changes at synapses.
• Activity-dependent signaling pathways such as those involving Cdc42 and Ephexin5 drive synapse growth and stabilization.
• Electrical synapse structure requires specific postsynaptic scaffold isoforms.
• Exercise-induced upregulation of CD55 protects against synaptic loss in Parkinson's disease models.
• Understanding synapse regulation can inform therapeutic strategies for neurodegenerative and psychiatric disorders.
What Happens During regulation of synapse structure or activity?
Activity-Dependent Signaling Initiation
In simple terms: When neurons fire, they trigger chemical signals that start the process of changing synapse structure or strength.
Synaptic activity initiates intracellular signaling cascades that regulate spine and synapse formation. Key pathways involve calcium influx, kinase activation, and downstream effectors that remodel the cytoskeleton and gene expression. For example, activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization, linking neuronal activity to structural changes.
Cytoskeletal Remodeling
In simple terms: The internal skeleton of the synapse is rebuilt to change its shape and size.
Actin and its regulators control synapse structure and function by dynamically assembling and disassembling actin filaments. This remodeling underlies changes in dendritic spine morphology and synaptic strength. Actin dynamics are tightly coupled to signaling pathways that respond to synaptic activity.
Ubiquitin-Dependent Protein Turnover
In simple terms: Proteins at the synapse are tagged for destruction to eliminate or weaken synapses.
Ubiquitin-dependent regulation of the synapse involves the tagging of synaptic proteins with ubiquitin, leading to their degradation by the proteasome. This process controls synapse elimination, plasticity, and protein quality control. It is a key mechanism for activity-dependent remodeling of synaptic connections.
Complement-Mediated Synaptic Phagocytosis
In simple terms: Immune-like cells prune synapses by engulfing them, a process that can be regulated by protective factors.
Complement-mediated synaptic phagocytosis is a process where microglia or other phagocytes eliminate synapses tagged with complement proteins. In Parkinson's disease models, exercise training upregulates CD55, a complement inhibitor, to suppress this phagocytosis and protect synapses. This highlights an immune-surveillance mechanism in synapse regulation.
Scaffold and Adhesion Dynamics at Electrical Synapses
In simple terms: The structural support proteins at electrical synapses must be correctly assembled for the synapse to function.
Electrical synapse structure requires distinct isoforms of a postsynaptic scaffold, which are essential for proper synapse formation and function. These scaffolds organize gap junctions and associated proteins, and their isoform-specific roles are critical for synapse regulation.
Key Genes Involved in GO:0050803 regulation of synapse structure or activity
The following genes and proteins are key players in the regulation of synapse structure or activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cdc42 | Activity-dependent regulation of synapse growth and stabilization | Studied for its role in cytoskeletal dynamics and synaptic plasticity |
| Ephexin5 | Regulates Cdc42 activity in an activity-dependent manner | Key effector linking neuronal activity to synapse growth |
| CD55 | Complement inhibitor that suppresses synaptic phagocytosis | Upregulated by exercise to protect synapses in Parkinson's disease |
| Actin | Major cytoskeletal component controlling synapse structure | Central to spine morphology and synaptic function |
| Ubiquitin | Tags synaptic proteins for degradation | Regulates synapse elimination and plasticity |
| Proteasome | Degrades ubiquitinated synaptic proteins | Mediates protein turnover at synapses |
| Postsynaptic scaffold (isoforms) | Structural support at electrical synapses | Required for electrical synapse structure |
| Calcium/calmodulin-dependent kinases | Activity-dependent signaling | Regulate spine and synapse formation |
| Rho GTPases | Cytoskeletal regulators | Control actin dynamics at synapses |
| Complement proteins | Tag synapses for phagocytosis | Mediate synaptic pruning in disease |
| Microglia | Phagocytose synapses | Execute complement-mediated synaptic elimination |
| Neurotransmitter receptors | Mediate synaptic transmission | Their trafficking regulates synaptic activity |
| Scaffolding proteins (PSD-95 etc.) | Organize postsynaptic signaling complexes | Regulate synapse structure and function |
| Cell adhesion molecules | Maintain synaptic contacts | Influence synapse stability |
| Growth factors (BDNF etc.) | Modulate synaptic plasticity | Regulate activity-dependent synapse formation |
| Transcription factors (CREB etc.) | Activity-dependent gene expression | Control long-term synaptic changes |
How Is regulation of synapse structure or activity Regulated?
The regulation of synapse structure or activity is itself tightly controlled by multiple mechanisms. Activity-dependent intracellular signaling pathways, including calcium/calmodulin-dependent kinase cascades, modulate spine and synapse formation. Ubiquitin-dependent proteolysis provides a regulatory layer by controlling the abundance of synaptic proteins. Additionally, complement-mediated phagocytosis is regulated by inhibitors such as CD55, which can be upregulated by exercise. Actin dynamics are controlled by Rho GTPases and their regulators, which respond to synaptic activity. These regulatory mechanisms ensure that synapse structure and activity are appropriately tuned to neuronal activity patterns.
regulation of synapse structure or activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD55 | Parkinson's disease (synaptic phagocytosis) | Knockout and overexpression in neuronal cell lines or primary neurons |
| Cdc42 | Synaptic dysfunction in neurological disorders | Point mutation and knockout in iPSC-derived neurons |
| Ephexin5 | Synapse growth and stabilization defects | Knockout and knock-in in mouse models |
| Actin regulators | Cognitive disorders linked to spine abnormalities | Overexpression and knockout in primary neuronal cultures |
| Ubiquitin-proteasome components | Neurodegeneration with protein aggregation | Knockout and point mutation in cell lines |
Schizophrenia
Synaptic dysfunction is a core feature of schizophrenia, with alterations in synapse structure and activity contributing to cognitive deficits. Studies have highlighted the role of synaptic dysfunction in the pathophysiology of schizophrenia. Dysregulation of mechanisms controlling synapse regulation may underlie the synaptic abnormalities observed in this disorder.
Parkinson's Disease
In Parkinson's disease, complement-mediated synaptic phagocytosis contributes to synapse loss. Exercise training upregulates CD55 to suppress this phagocytosis, suggesting a protective mechanism. This links the regulation of synapse structure or activity to neurodegeneration and potential therapeutic interventions.
Other Neurological Disorders
Dysregulation of synapse structure or activity is implicated in various neurological conditions, including those involving cytoskeletal abnormalities and protein degradation defects. Understanding these mechanisms may provide insights into disease pathogenesis and treatment.
From regulation of synapse structure or activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CD55 increase synaptic phagocytosis? | CD55 knockout cell line or primary neurons |
| How does Cdc42 activity affect synapse growth? | Cdc42 point mutation (constitutively active/inactive) knock-in |
| What is the role of Ephexin5 in activity-dependent synapse stabilization? | Ephexin5 knockout and tagged knock-in for localization |
| How do actin regulators control spine morphology? | Overexpression of actin mutants in neurons |
| Does ubiquitin-dependent degradation regulate synapse elimination? | Knockout of E3 ligases or proteasome subunits |
| What isoforms of postsynaptic scaffold are required for electrical synapses? | Isoform-specific knockout and knock-in |
How to Study the regulation of synapse structure or activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Spine density and morphology | Assessing structural changes at synapses |
| Electrophysiology | Synaptic strength and plasticity | Measuring functional regulation of synapses |
| Proteomics | Protein abundance and ubiquitination | Identifying ubiquitin-dependent regulation |
| RNA-seq | Gene expression changes | Discovering activity-dependent regulators |
| Super-resolution imaging | Nanoscale synapse organization | Visualizing scaffold and receptor localization |
| Phagocytosis assays | Microglial engulfment of synapses | Studying complement-mediated pruning |
| Live-cell imaging | Dynamic cytoskeletal changes | Tracking actin remodeling in real time |
Imaging Synapse Structure
Advanced microscopy techniques such as confocal, two-photon, and super-resolution imaging allow visualization of dendritic spines and synaptic puncta. These methods measure changes in synapse number, size, and morphology in response to genetic or activity manipulations.
Electrophysiology
Patch-clamp and extracellular recording techniques measure synaptic activity and plasticity, including long-term potentiation (LTP) and long-term depression (LTD). These functional assays complement structural studies to assess regulation of synapse activity.
Proteomics and Ubiquitin Analysis
Mass spectrometry-based proteomics can identify ubiquitinated synaptic proteins and quantify changes in protein abundance. This approach helps dissect ubiquitin-dependent regulation of the synapse.
Transcriptomics and Activity-Dependent Gene Expression
RNA sequencing (RNA-seq) after neuronal activity stimulation reveals activity-dependent gene expression programs that regulate synapse structure and function. This can identify novel regulators and signaling pathways.
How CRISPR Can Be Used to Study GO:0050803 regulation of synapse structure or activity
Knockout
CRISPR knockout (KO) is used to eliminate genes involved in synapse regulation, such as CD55 or Cdc42, to assess their loss-of-function effects on synapse structure and activity. KO models help determine whether a gene is necessary for normal synaptic function.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to activate/inactivate specific protein functions. For example, point mutations in Cdc42 can lock it in active or inactive states to study its role in synapse growth.
Knock-in
Knock-in models allow the introduction of reporter tags or disease-relevant mutations into endogenous loci. Tagged knock-in of Ephexin5 or scaffold proteins enables visualization and biochemical analysis of these proteins in their native context.
Overexpression
Overexpression of genes such as actin regulators or CD55 can test gain-of-function effects on synapse regulation. This approach is useful for identifying sufficiency of a gene to drive synaptic changes.
How EDITGENE Supports regulation of synapse structure or activity Research
Researchers studying regulation of synapse structure or activity-related genes often need to determine whether a candidate gene is causally involved in synaptic phenotypes. This requires precise genetic manipulation, which can be achieved through CRISPR-based cell models. EDITGENE offers a comprehensive suite of services to support such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of synapse structure or activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| APP Knockout HEK293 Cell Line | EDC09598 | Human | 351 | Details Get a Quote |
| SLC17A8 Knockout HEK293 Cell Line | EDJ-KQ3835 | Human | 246213 | Details Get a Quote |
| SLC17A6 Knockout HEK293 Cell Line | EDJ-KQ15300 | Human | 57084 | Details Get a Quote |
| SLC17A7 Knockout HEK293 Cell Line | EDJ-KQ15301 | Human | 57030 | Details Get a Quote |
| PPT1 Knockout HEK293 Cell Line | EDJ-KQ17893 | Human | 5538 | Details Get a Quote |
| SLC17A7 Knockout HCT 116 Cell Line | EDJ-KQ45998 | Human | 57030 | Details Get a Quote |
| PPT1 Knockout A-549 Cell Line | EDJ-KQ22744 | Human | 5538 | Details Get a Quote |
| PPT1 Knockout HCT 116 Cell Line | EDJ-KQ22745 | Human | 5538 | Details Get a Quote |
| PPT1 Knockout HeLa Cell Line | EDJ-KQ22746 | Human | 5538 | Details Get a Quote |
| APP Knockout A-549 Cell Line | EDJ-KQ25351 | Human | 351 | Details Get a Quote |
| APP Knockout HCT 116 Cell Line | EDJ-KQ25352 | Human | 351 | Details Get a Quote |
| APP Knockout HeLa Cell Line | EDJ-KQ25353 | Human | 351 | Details Get a Quote |
| PPT1 Knockout Hep-G2 Cell Line | EDJ-KZ411 | Human | 5538 | Details Get a Quote |
| SLC17A7 Knockout HeLa Cell Line | EDJ-KQ56790 | Human | 57030 | Details Get a Quote |
| SLC17A6 Knockout HeLa Cell Line | EDJ-KQ56795 | Human | 57084 | Details Get a Quote |
Displaying Records 1 To 15 Of 22 Records
Frequently Asked Questions About regulation of synapse structure or activity
What is GO:0050803?
GO:0050803 is the Gene Ontology term for regulation of synapse structure or activity, defined as any process that modulates the physical form or activity of a synapse, the junction between a neuron and a target cell.
What genes are involved in regulation of synapse structure or activity?
Key genes include Cdc42, Ephexin5, CD55, actin, ubiquitin, and various synaptic scaffolds, as identified in published studies.
How is synapse structure regulated?
Synapse structure is regulated by activity-dependent signaling, actin cytoskeleton remodeling, ubiquitin-dependent protein degradation, and complement-mediated phagocytosis.
What diseases are associated with dysregulation of synapse structure or activity?
Dysregulation is associated with schizophrenia, Parkinson's disease, and other neurological disorders.
What methods are used to study synapse regulation?
Common methods include imaging (confocal, super-resolution), electrophysiology, proteomics, and RNA-seq.
How can CRISPR be used to study synapse regulation?
CRISPR enables knockout, point mutation, knock-in, and overexpression of genes to test their causal roles in synapse structure and activity.
What is the role of CD55 in synapse regulation?
CD55 is a complement inhibitor that suppresses complement-mediated synaptic phagocytosis; its upregulation by exercise protects synapses in Parkinson's disease models.
How does Cdc42 regulate synapses?
Cdc42 is regulated by Ephexin5 in an activity-dependent manner to drive synapse growth and stabilization.
What is the role of ubiquitin in synapse regulation?
Ubiquitin tags synaptic proteins for degradation, controlling synapse elimination and plasticity.
How does actin contribute to synapse structure?
Actin and its regulators control the dynamic remodeling of the cytoskeleton, which underlies changes in dendritic spine morphology and synaptic function.
Conclusion
GO:0050803 (regulation of synapse structure or activity) is a fundamental biological process that integrates activity-dependent signaling, cytoskeletal dynamics, protein degradation, and immune-mediated pruning to shape synaptic connections. Its dysregulation is linked to major neurological and psychiatric disorders, making it a critical area of research. CRISPR-based models and advanced methodologies offer powerful tools to dissect the molecular mechanisms and identify therapeutic targets. EDITGENE's comprehensive services support researchers in this endeavor, from custom cell model generation to high-throughput screening and bioinformatics.
References
- 1. DiAntonio A et al.. 2004. Ubiquitin-dependent regulation of the synapse.. Annu Rev Neurosci 27:223-46 PMID: 15217332
- 2. Yao H et al.. 2024. Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease.. J Neuroinflammation 21(1):246 PMID: 39342308
- 3. Petshow S et al.. 2025. Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization.. Sci Adv 11(13):eadp5782 PMID: 40138406
- 4. Gentile JE et al.. 2022. Control of Synapse Structure and Function by Actin and Its Regulators.. Cells 11(4) PMID: 35203254
- 5. Saneyoshi T et al.. 2010. Regulation of spine and synapse formation by activity-dependent intracellular signaling pathways.. Curr Opin Neurobiol 20(1):108-15 PMID: 19896363
- 6. Mısır E et al.. 2023. Synaptic dysfunction in schizophrenia.. Synapse 77(5):e22276 PMID: 37210696
- 8. Michel JC et al.. 2023. Electrical synapse structure requires distinct isoforms of a postsynaptic scaffold.. PLoS Genet 19(11):e1011045 PMID: 38011265
